Analysed BICARA THERAPEUTICS INC (BCAX:NASDAQ) News Sources
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05-10-2026
yahoo.com
Bicara Therapeutics ASCO Data Bolster Ficerafusp Alfa in Head and Neck Cancer
22-05-2026
marketbeat.com
What Does the Bicara Therapeutics CEO's Sale of 15,000 Shares Mean for Investors?
13-06-2026
fool.com
What is the current price of BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The current price of BICARA THERAPEUTICS INC (BCAX:NASDAQ) is $17.5.
BICARA THERAPEUTICS INC (BCAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BICARA THERAPEUTICS INC (BCAX:NASDAQ) since the previous trading day is $0.24.
BICARA THERAPEUTICS INC (BCAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BICARA THERAPEUTICS INC (BCAX:NASDAQ) since the previous trading day is 1.3905%.
What is the most recent average sentiment score for BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The most recent average sentiment score for BICARA THERAPEUTICS INC (BCAX:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for BICARA THERAPEUTICS INC (BCAX:NASDAQ)?
The most recent sentiment for BICARA THERAPEUTICS INC (BCAX:NASDAQ) is .
SEC-8K** Filing Available For BICARA THERAPEUTICS INC (BCAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.